218 related articles for article (PubMed ID: 23112839)
1. Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.
Sonne S; Shekhawat PS; Matern D; Ganapathy V; Ignatowicz L
PLoS One; 2012; 7(10):e47729. PubMed ID: 23112839
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.
Shekhawat PS; Srinivas SR; Matern D; Bennett MJ; Boriack R; George V; Xu H; Prasad PD; Roon P; Ganapathy V
Mol Genet Metab; 2007 Dec; 92(4):315-24. PubMed ID: 17884651
[TBL] [Abstract][Full Text] [Related]
3. Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) Mice.
Shekhawat PS; Yang HS; Bennett MJ; Carter AL; Matern D; Tamai I; Ganapathy V
Pediatr Res; 2004 Sep; 56(3):323-8. PubMed ID: 15240869
[TBL] [Abstract][Full Text] [Related]
4. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
Filippo CA; Ardon O; Longo N
Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
[TBL] [Abstract][Full Text] [Related]
7. Carnitine transport and fatty acid oxidation.
Longo N; Frigeni M; Pasquali M
Biochim Biophys Acta; 2016 Oct; 1863(10):2422-35. PubMed ID: 26828774
[TBL] [Abstract][Full Text] [Related]
8. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.
Dinarvand N; Karimi F; Azizi R; Rastaghi S; Sheikhi A; Pourfarzam M
Mol Biol Rep; 2023 Mar; 50(3):2061-2066. PubMed ID: 36539562
[TBL] [Abstract][Full Text] [Related]
11. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.
Juraszek B; Nałęcz KA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504
[TBL] [Abstract][Full Text] [Related]
12. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
[TBL] [Abstract][Full Text] [Related]
13. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
14. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.
Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I
Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060
[TBL] [Abstract][Full Text] [Related]
16. Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health.
Shekhawat PS; Sonne S; Carter AL; Matern D; Ganapathy V
J Crohns Colitis; 2013 Jul; 7(6):e197-205. PubMed ID: 22999781
[TBL] [Abstract][Full Text] [Related]
17. Embryonic lethality in mice due to carnitine transporter OCTN2 defect and placental carnitine deficiency.
Shekhawat PS; Sonne S; Matern D; Ganapathy V
Placenta; 2018 Sep; 69():71-73. PubMed ID: 30213487
[TBL] [Abstract][Full Text] [Related]
18. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
19. Human macrophage differentiation induces OCTN2-mediated L-carnitine transport through stimulation of mTOR-STAT3 axis.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Milioli M; Di Lascia M; Bernuzzi G; Dall'Asta V
J Leukoc Biol; 2017 Mar; 101(3):665-674. PubMed ID: 27733576
[TBL] [Abstract][Full Text] [Related]
20. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
